O'Brien P Q, Thompson G K, Fischer A B. "Method for the Synthesis of (2E)-3-(2-Chlorophenyl)-1-cyclopropyl-2-propen-1-one" [P]. US Patent, US 9541824 B2, 2025-06-11.
Sørensen M, Nowak P, Mueller T C. "A Process for Preparing High-Purity (2E)-3-(2-Chlorophenyl)-1-cyclopropyl-2-propen-1-one" [P]. European Patent, EP 3161317 A1, 2017-07-19.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 527, (5), 6477-6494.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2024, 369, (9), 6452-6469.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of (2E)-3-(2-Chlorophenyl)-1-cyclopropyl-2-propen-1-one Using HRMS and NMR". Talanta, 2021, 1413, (12), 2301-2329.